Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
Angela Martinez‐Monleon(University of Gothenburg), Tommy Martinsson(University of Gothenburg)
Cited by 22
Related Papers
11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma
|Cell Reports|2020|53
Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis
|International Journal of Oncology|2008|20